Issue 14/2021
Content (14 Articles)
Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat
- Heart Failure
- Current Opinion
Andrew J. S. Coats, Heli Tolppanen
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
- Open Access
- Systemic Lupus Erythematosus
- Leading Article
Stefan F. H. Neys, Jasper Rip, Rudi W. Hendriks, Odilia B. J. Corneth
Pharmacological Management of Acute Endodontic Pain
- Paracetamol
- Review Article
Asma A. Khan, Anibal Diogenes
Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review
- Open Access
- Osteoporosis
- Review Article
Laura P. B. Elbers, Hennie G. Raterman, Willem F. Lems
Comment on: “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”
- COVID-19
- Letter to the Editor
Song Zhang, Feng Zhu
Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”
- SARS-CoV-2
- Letter to the Editor
Nadine Ahmed, John Paul Pezacki
Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
- Inflammatory Bowel Disease
- Correction
Jurij Hanzel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath, Brian G. Feagan
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
- Open Access
- Budesonide
- Correction
Young-A Heo